Back to Principal Financial Group Inc. Principal Financial Group Inc.

ARWRARWR

Showing 9 of 29 quarters

Position history for Principal Financial Group Inc.Principal Financial Group Inc.'s holdings in Arrowhead Pharmaceuticals, Inc.

Yes. Principal Financial Group holds 367,315 shares of ARWR (Arrowhead Pharmaceuticals), worth $24M, as of its Q3 2026 13F filing. It reduced the position by 147,343 shares (-28.6%) from Q2 2026. Principal Financial Group has held ARWR in every 13F on record since Q3 2019, 29 quarterly filings.

Current Value

$24M

Current Shares

367,315

Total Value Change

+$18.4M

Total Shares Change

+76,321

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
367,315
-28.6%
$24M0.0%$65.45
0
2026-Q2
Increased
514,658
+5.0%
$41.9M0.0%$81.51
31
2026-Q1
Decreased
490,122
-31.5%
$30.7M0.0%$62.70
0
2025-Q4
Decreased
715,539
-8.3%
$47.5M0.0%$66.39
0
2025-Q3
Increased
780,132
+25.2%
$26.9M0.0%$34.49
35
2025-Q2
Decreased
623,097
-0.9%
$9.8M0.0%$15.80
0
2025-Q1
Increased
629,075
+117.8%
$8M0.0%$12.74
44
2024-Q4
Decreased
288,884
-0.7%
$5.4M0.0%$18.80
0
2024-Q3
Decreased
290,994
-31.5%
$5.6M0.0%$19.37
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used